Burjeel Holdings IPO oversubscribed by 29 times
The initial public offering (IPO) of Burjeel Holdings, a leading MENA private healthcare services provider, received significant demand from investors and closed 29 times oversubscribed.
Stay updated with breaking news from Lead Manager. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The initial public offering (IPO) of Burjeel Holdings, a leading MENA private healthcare services provider, received significant demand from investors and closed 29 times oversubscribed.
Burjeel Holdings has announced the successful completion of the bookbuild and public subscription process for its Initial Public Offering (IPO) on the Abu Dhabi Securities Exchange (ADX). The price for the Offering has been set at Dhs2.00 per ordinary share (the Final Offer Price), and the offering size confirmed at 550,729,221 ordinary shares
RIYADH: Knowledge Tower Trading Co. will conduct an initial public offering of its 350,000 ordinary shares on the Nomu-Parallel Market according to the company’s plans, revealed by its financial advisor Watheeq Capital. This represents around 20 percent of Knowledge Tower’s SR18 million ($5 million) share capital, which is divided into 1.75 million shares, as it was stated in
Mumbai (Maharashtra) [India], September 23 (ANI/PNN): QMS Medical Allied Services (QMS) engaged in the business of marketing and distribution of a wide range of medical and healthcare devices and accessories, proposes to open its initial public offer (IPO) of 47,00,000 Equity Shares of Rs 10 each for cash at a price of Rs 121 per equity share aggregating to Rs 5,687 Lakh on the NSE Emerge platform. Of this, 19,00,000 equity shares are offered for sale while fresh issue is of 28,00,000 equity shares. The issue will close on September 30, 2022. The net proceeds from the IPO will be utilized to m...
Regulatory News: Not for release, either directly or indirectly, in the United States, Canada, Australia or Japan. Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company